Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Appili, Astex, Betterlife, Clover, Codagenix, Corvus, Enlivex, Gilead Sciences, Hightide, Hutchmed, Johnson & Johnson, Kyowa Kirin, Moderna, Newsoara, Otsuka, Phoxbio, Reven, Rhizen, SAB, Valneva, Zenith Epigenetics.